Award
NIH Reporter #5R01CA279180-04
Dissecting the role and mechanism of EML4-ALK condensates in oncogenic signaling and tumor growth
Recipient
Not specified
Award Amount
$670,214.00
Ceiling
$670,214.00
Awarded
April 11, 2023
Identifier
5R01CA279180-04
Research project funded by the National Cancer Institute to study EML4-ALK condensates in lung cancer and develop targeted therapies, with a budget of $670,214.
Description
This project aims to understand the role of biomolecular condensates in ALK-driven lung cancer and develop targeted therapeutic strategies. The award is funded by the National Cancer Institute with a total budget of $670,214 for fiscal year 2026. The project duration is from April 11, 2023, to March 31, 2028.